Immunoprecipitation and immunoblot assays.

DC Dmitry V. Chouljenko
NJ Nithya Jambunathan
VC Vladimir N. Chouljenko
MN Misagh Naderi
MB Michal Brylinski
JC John R. Caskey
KK Konstantin G. Kousoulas
request Request a Protocol
ask Ask a question
Favorite

Confluent Vero cells in T75 flasks were infected with the double-tagged recombinant virus VC1 (gK-V5 and UL20-FLAG), DC474-480, or F strain virus at an MOI of 2. At 24 hpi, the infected cells were lysed with NP-40 cell lysis buffer (Life Technologies) supplemented with protease inhibitor tablets (Roche). The samples were centrifuged at 13,000 rpm for 10 min at 4°C. The supernatants were then used for immunoprecipitation. The proteins from virus-infected cells were immunoprecipitated using protein G magnetic Dynabeads according to the manufacturer's instructions (Invitrogen). Briefly, the beads were bound to their respective antibodies and left on a nutator for 10 min, followed by the addition of cell lysates. The lysate-bead mixture was kept on the nutator for 10 min at room temperature and subsequently washed three times with phosphate-buffered saline (PBS). The protein was eluted from the magnetic beads in 40 μl of elution buffer and used for immunoblot assays. Sample buffer containing 5% β-mercaptoethanol was added to the protein and heated at 55°C for 15 min. Proteins were resolved in a 4-to-20% SDS-PAGE gel and immobilized on nitrocellulose membranes. Immunoblot assays were carried out using monoclonal mouse anti-FLAG antibody (Sigma-Aldrich, Inc., St. Louis, MO), monoclonal mouse anti-V5 antibody (Invitrogen), mouse monoclonal anti-VP5 antibody, horseradish peroxidase (HRP)-conjugated goat anti-mouse antibodies (Abcam, Inc., Cambridge, MA), polyclonal rabbit anti-UL37 antibody (a gift from Frank J. Jenkins, University of Pittsburgh Cancer Institute), and HRP-conjugated goat anti-rabbit and anti-mouse antibodies (Abcam, Inc., Cambridge, MA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A